Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/04/2007US7304072 Spiro compounds
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304070 eg 8-(4-{[3-(2-methylphenyl)(1,2,4-oxadiazol-5-yl)]methoxy}phenyl)-1,3-dipropyl-1,3,7-trihydropurine-2,6-dione; atherosclerosis, angiogenesis, diabetic retinopathy, cancer, asthma, diarrhea, senile dementia, Alzheimer's disease, or Parkinson's disease
12/04/2007US7304069 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
12/04/2007US7304068 Viricide against herpes virus; 3-(2-Fluoropyridin-4-yl)-2-phenyl-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidine; chemical synthesis
12/04/2007US7304067 (S)-2-[(R)-5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories
12/04/2007US7304066 Pyridyl cyanoguanidine compounds
12/04/2007US7304065 Melanin concentrating hormone antagonists
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304063 Inhibitors of Akt activity
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304058 For therapy of Alzheimer's disease, depression
12/04/2007US7304057 Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator
12/04/2007US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
12/04/2007US7304055 Succinoylamino lactams as inhibitors of Aβ protein production
12/04/2007US7304054 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007US7304051 Quinoxaline compounds
12/04/2007US7304050 Antibacterial agents
12/04/2007US7304049 Succinamides N-monosubstituted with with a dibenzo[b,e]azepinone group that inhibit the production of A beta-peptide, acting to prevent the formation of neurological deposits of amyloid protein; treating Alzheimer's Disease
12/04/2007US7304048 For use as anti-inflammatory agents
12/04/2007US7304047 Method of treating substance abuse with quetiapine
12/04/2007US7304044 Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins
12/04/2007US7304043 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
12/04/2007US7304040 Suppression of post-transplant arteriosclerosis
12/04/2007US7304039 Glucose-based compounds with affinity to P-selectin
12/04/2007US7304038 Therapeutic composition and method of supporting the immune system
12/04/2007US7304037 Cytostatic conjugates with integrin ligands
12/04/2007US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007US7304032 CD-10 activated prodrug compounds
12/04/2007US7304018 Amidoacetonitrile compounds and their use as pesticides
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007US7303871 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating damaging effects of gluten
12/04/2007US7303868 Mutant bank
12/04/2007US7303771 A mixture for lowering low-density lipoprotein cholesterol, C Reactive protein, homocysteines and triglycerides, and increasing high-density lipoprotein comprising 560 mg of alfalfa sprout powder, 230 mcg of folic acid, 12.5 mg of Vitamin B-6 and 500 mcg of Vitamin B-12; oral dosage forms
12/04/2007US7303768 Gastrointestinal disorders; antiulcer agents
12/04/2007US7303765 Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/04/2007US7303764 For therapy of psychosis, acute mania or mild anxiety states
12/04/2007US7303763 Noncracking complex; stability
12/04/2007US7303761 Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
12/04/2007US7303760 Method for treating multi-drug resistant tumors
12/04/2007US7303758 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices
12/04/2007US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
12/04/2007US7303753 Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
12/04/2007US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
12/04/2007US7302954 Reduces inflow rate of a certain smoke component
12/04/2007CA2445744C Antiviral nucleoside derivatives
12/04/2007CA2427856C The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2383140C Ppar.alpha. and ppar.gamma. inhibitors
12/04/2007CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists
12/04/2007CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies
12/04/2007CA2321826C Pharmaceutical formulations of taxanes
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007CA2276170C Sustained analgesia achieved with buprenorphine
12/04/2007CA2265815C Formulations for topical use
12/04/2007CA2265767C Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
12/04/2007CA2263705C Novel sandwich liposome complexes comprising a biologically active agent
12/04/2007CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007CA2239313C Solid compound, its preparation and use in medicine
12/04/2007CA2233315C Pharmaceutical compositions containing hydroximic acid derivatives
12/04/2007CA2230950C Solid drug forms obtainable by extrusion of an isomalt-containing polymer/active ingredient melt
12/04/2007CA2227039C One pot synthesis of 2-oxazolidinone derivatives
12/04/2007CA2223894C Dinucleotides useful for the treatment of lung disease
12/04/2007CA2212205C Use of xanthine derivatives for the modulation of apoptosis
12/04/2007CA2210533C Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
12/04/2007CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof
12/04/2007CA2193097C Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
12/04/2007CA2192965C Anandamide analogue compositions and method of treating intraocular hypertension using same
12/04/2007CA2185984C Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor
11/2007
11/30/2007CA2591352A1 Treatment for herpes simplex virus and other infectious diseases
11/29/2007WO2007137294A2 Dexamethasone-eluting endoprosthesis to promote human coronary artery endothelial cell migration
11/29/2007WO2007137279A2 Herv-k antigens, antibodies, and methods
11/29/2007WO2007137267A2 Protein production using eukaryotic cell lines
11/29/2007WO2007137258A2 C-glycolipids with enhanced th-1 profile
11/29/2007WO2007137255A2 Bacterial thioredoxin reductase inhibitors and methods for use thereof
11/29/2007WO2007137247A2 Treatment for depressive disorders
11/29/2007WO2007137244A1 Melatonin agonist treatment
11/29/2007WO2007137236A2 Drug loaded contrast agents: combining diagnosis and therapy
11/29/2007WO2007137227A1 Treatment for depressive disorders
11/29/2007WO2007137224A2 Method of treatment
11/29/2007WO2007137223A2 Configurations for chlorine dioxide production
11/29/2007WO2007137220A2 Compositions and methods for inhibiting expression of ikk-b gene
11/29/2007WO2007137216A2 Gastroretentive sustained release formulations
11/29/2007WO2007137214A1 Methods for preventing or treating acute and chronic pain
11/29/2007WO2007137206A2 Unit dose formulations comprising an inhalable solution of albuterol
11/29/2007WO2007137204A2 Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the same
11/29/2007WO2007137200A2 Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers
11/29/2007WO2007137190A2 Functionally diverse macromolecules and their synthesis
11/29/2007WO2007137167A2 Co-therapy for the treatment of epilepsy
11/29/2007WO2007137164A2 Co-therapy for the treatment of epilepsy and related disorders
11/29/2007WO2007137163A2 Abc transporter ligand
11/29/2007WO2007137098A2 Sulfonyl-substituted bicyclic compounds as modulators of ppar
11/29/2007WO2007137080A2 Compounds and compositions as channel activating protease inhibitors
1 ... 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 ... 7860